Do you routinely use thrombopoietin receptor agonists (like romiplostim) to address chemotherapy-induced thrombocytopenia in solid tumor pediatric oncology patients?
Community PollStarted
Which diagnoses do you consider use of thrombopoietin receptor agonists for to address chemotherapy induced thrombocytopenia in pediatric oncology patients?
10 physicians have voted
Join Mednetto vote and see how they answered.